HIV-2 Antiviral Potency and Selection of Drug Resistance Mutations by the Integrase Strand Transfer Inhibitor Elvitegravir and NRTIs Emtricitabine and Tenofovir In Vitro-Reference-Cited by-同舟云学术

HIV-2 Antiviral Potency and Selection of Drug Resistance Mutations by the Integrase Strand Transfer Inhibitor Elvitegravir and NRTIs Emtricitabine and Tenofovir In Vitro

Published:2013-04-01 Issue:4 Volume:62 Page:367-374
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Andreatta Kristen,Miller Michael D.,White Kirsten L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference44 articles.

1. Chaudhuri RR, et al..;Sharp;The origins of acquired immune deficiency syndrome viruses: where and when Philos Trans R Soc Lond B Biol Sci,2001

2. HIV-2: the forgotten AIDS virus.;de Silva;Trends Microbiol,2008

3. Update on human immunodeficiency virus (HIV)-2 infection.;Campbell-Yesufu;Clin Infect Dis,2011

4. . Antiretroviral drug resistance in human immunodeficiency virus type 2.;Ntemgwa;Antimicrob Agents Chemother,2009

5. . Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.;Witvrouw;Antivir Ther,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes of Integrase Strand Transfer Inhibitors Containing Antiretroviral Therapy in HIV-2: A Narrative Review;Infectious Diseases and Therapy;2024-05-09

2. Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds;International Journal of Molecular Sciences;2023-03-21

3. High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients;International Journal of Molecular Sciences;2022-11-18

4. Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2;The Journal of Infectious Diseases;2020-01-22

5. Comparison of the Antiviral Activity of Bictegravir against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants;Antimicrobial Agents and Chemotherapy;2019-05